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1  | INTRODUC TION
Antibiotics are medicines that fight bacterial infection, but there is a 
growing problem of antibiotic resistance when bacteria become able to 
resist the effects of antibiotics. Antibiotic‐resistant genes spread in the 
environment quickly due to overuse of antibiotics which imposes a strong 
selection pressure favoring resistance. For instance, humans use a range 
of antibiotics in agriculture and fish farming, as standard prophylactic 
measures, which leads to the widespread evolution of antibiotic‐resis‐
tant genes (Economou & Gousia, 2015). A common enzymatic resistance 
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Abstract
Bacterial resistance to antibiotics is a serious medical and public health concern world‐
wide.	Such	resistance	is	conferred	by	a	variety	of	mechanisms,	but	the	extensive	vari‐
ability in levels of resistance across bacteria is a common finding. Understanding the 
underlying evolutionary processes governing this functional variation in antibiotic 
resistance is important as it may allow the development of appropriate strategies to 
improve treatment options for bacterial infections. The main objective of this study 
was to examine the functional evolution of β‐lactamases, a common mechanism of 
enzymatic	resistance	that	inactivates	a	widely	used	class	of	antibiotics.	We	first	ob‐
tained β‐lactamase protein sequences and minimal inhibitory concentration (MIC), a 
measure	of	antibiotic	function,	from	previously	published	literature.	We	then	used	
a molecular phylogenetic framework to examine the evolution of β‐lactamase func‐
tional	activity.	We	found	that	the	functional	activity	of	antibiotic	resistance	mediated	
by β‐lactamase has evolved in a convergent manner within molecular classes, but is 
not associated with any single amino acid substitution. This suggests that the dynam‐
ics of convergent evolution in this system can vary between the functional and mo‐
lecular	(sequence)	levels.	Such	disassociation	may	hamper	bioinformatic	approaches	
to antibiotic resistance determination and underscore the need for (less efficient but 
more effective) activity assays as an essential step in evaluating resistance in a given 
case.
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mechanism used by several groups of bacteria is the production of “β‐lac‐
tamase” enzymes that inactivate β‐lactam antibiotics (an important class 
of antibiotics which includes penicillins, cephalosporins, carbapenems, 
and monobactam). There are more than 1,300 natural lactamases, classi‐
fied into four molecular classes (A, B, C, and D) (Ambler, 1980; Ambler et 
al.,	1991;	Bush,	2013;	Bush	&	Jacoby,	2010;	Bush,	Jacoby,	&	Medeiros,	
1995). The active site of class A, C, and D enzymes contains serine amino 
acid, while class B contains histidine along with Zn metal (Bebrone, 2007). 
In addition, class B (metallo‐β‐lactamase) has been classified into three 
subclasses B1, B2, and B3 (Bebrone, 2007). Based on substrate profile in‐
hibitors, β‐lactamases are classified into functional subgroups such as 2a, 
2b,	2be,	and	2c.	(Bush,	1989b,	1989a;	Bush	&	Jacoby,	2010;	Bush	et	al.,	
1995).	Significant	progress	in	sequencing	technologies	led	to	a	large	num‐
ber of class A β‐lactamases in sequence database, in some cases being 
deposited	under	 inappropriate	classification	 (Philippon,	Slama,	Dény,	&	
Labia, 2016). The class A enzymes can be further classified in subclasses 
A1 and A2 based on phylogenetic clustering (Philippon et al., 2016). 
Functional class B β‐lactamases, which appeared more than two billion 
years ago, suggest that resistance to antibiotics long predates their use 
in medicine (D’Costa et al., 2011). The functional classification of β‐lact‐
amase and its correlation with their distinct molecular structure has been 
described by Bush et al. (1995), and the functional evolution of super‐
family class B β‐lactamase has been studied by Alderson et al (Alderson, 
Barker, & Mitchell, 2014). However, Alderson et al. (Alderson et al., 2014) 
were unable to unambiguously demonstrate whether functional class B 
enzymes have one or two separate evolutionary origins (Alderson et al., 
2014). Antibiotic resistance conferred by β‐lactamases spreads rapidly, 
(sometimes facilitated by horizontal gene transfer (Barlow,2009; Varsha 
K	Vaidya,	2011;	Doi,	Adams‐Haduch,	Peleg,	&	D'Agata,	2012;	Warnes,	
Highmore, & Keevil, 2012). This information helps to understand the evo‐
lution of this resistance and to develop strategies for managing bacterial 
infections in humans, livestock, or other animals before they become a 
major epidemiological event. The number of β‐lactamase enzymes is reg‐
ularly increasing, but their functional evolution remains unclear.
Convergent evolution refers to similarities that have evolved in‐
dependently rather than being inherited from a common ancestor. 
“Convergence” is often used in a very general sense, but can apply 
to several types of characteristics, or levels, such as function and 
structure	 (Doolittle,	 1994;	 Speed	 &	 Arbuckle,	 2016).	 Several	 en‐
zymes have developed the ability to catalyze the same reactions on 
separate occasions, such as those involved in the hydrolysis of pep‐
tide bonds (Rawlings & Barrett, 1993). Consequently, the structure 
of a protein's active site(s) determines the biochemical functions, but 
enzymes within the same structural class may have different roles 
or variable activity levels. Conversely, the convergence of enzymatic 
functions is a common phenomenon. For instance, the hydrolysis of 
peptide bonds has evolved many times and serine proteases have 
evolved at least three times (Doolittle, 1994).
The terms “iso‐convergent” and “allo‐convergent” can be applied 
to the study of convergent evolution to gain a finer‐scale under‐
standing of the dynamics of convergence (Pontarotti & Hue, 2016). 
Iso‐convergent traits have converged from the same ancestral state 
(traditionally “parallel evolution”), whereas allo‐convergent traits 
have converged from different ancestral states. The allo‐convergent 
evolution of enzyme function results in two distinct, but sometimes 
joint, effects. For example, (a) nonhomologous enzymes deliver the 
same transformation, as expressed by the same four‐digit enzyme 
commission (EC) number; (b) the same (four‐digit EC) or related 
(same three‐digit EC) enzyme transformation is effected by a sim‐
ilar disposition of residues in the active site. These two situations 
are not exclusive because two enzymes are assigned to both classes 
if they perform exactly the same overall reaction with the same 
mechanism	 (Doolittle,	 1994;	 Gherardini,	 Wass,	 Helmer‐Citterich,	
&	Sternberg,	2007).	The	 independent	evolution	of	 the	 same	 func‐
tion, most often using different mechanisms, but sometimes using 
different catalytic mechanisms for essentially the same mechanism, 
is well documented for proteins of different families of nonhomolo‐
gous enzymes (Gherardini et al., 2007). However, this phenomenon 
is rarer within homologous superfamilies. Iso‐convergence has been 
documented in the “HAD (haloacid dehalogenase) superfamily” of 
proteins (Burroughs, Allen, Dunaway‐Mariano, & Aravind, 2006). 
Burroughs et al. (2006) deduced the evolutionary history of the 
HAD superfamily and showed that it contains 33 large families of 
three kingdoms and that diversification within archaeal, bacterial, 
and eukaryotic domains originated from an ancestral common HAD 
superfamily.
This study investigated whether and to what extent convergent 
functional evolution occurs in β‐lactamases and whether this func‐
tion can be predicted based on particular amino acid substitutions. 
We	used	the	minimum	inhibitory	concentration	(MIC)	as	a	measure	
of functional activity of β‐lactamase enzymes, a standard tech‐
nique in diagnostic laboratories to determine the susceptibility of 
organisms to antimicrobials (Andrews, 2001). The MIC is the lowest 
concentration of an antimicrobial that inhibits the visible growth of 
microorganisms after overnight incubation. Hence, high MICs corre‐
spond to a greater resistance to that antibiotic. A few studies have 
reported the presence of convergent evolution in β‐lactamases, but 
they have been based on the similarity of molecular sequences and 
the similarity of the structure of the active site of proteins rather than 
on demonstrated resistance to antibiotics, and have generally been 
small‐scale studies using a few enzymes (Hibbert‐rogers, Heritage, 
Todd, & Hawkey, 1994; 1997, & Perez‐Diaz, 11997). Moreover, the 
phylogenetic relationships within the molecular classes of β‐lact‐
amases remain poorly understood. Therefore, the current study in‐
vestigates the functional evolution across the various superfamilies/
classes of β‐lactamases for the first time.
F I G U R E  1   Class A (Cefepime): The midpoint‐rooted phylogenetic tree was constructed by maximum‐likelihood method based on the 
multiple sequence alignment. Bootstrap values are shown on each node. The phylogenetic tree contains class A β‐lactamases. The color of 
the branch (also in scale bar) indicates functional activity of enzymes against cefepime β‐lactam antibiotic. Blue through red color indicated 
susceptible to resistance functional activity
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2  | MATERIAL S AND METHODS
2.1 | Data collection
The β‐lactamase amino acid sequences were retrieved from the 
Antibiotics Resistance Gene‐ANNOTation (ARG‐ANNOT) database 
(Gupta et al., 2014). A total of 1,147 sequences from the four mo‐
lecular classes (A‐D) were recovered. All sequences were checked 
in the NCBI PubMed database (http://www.ncbi.nlm.nih.gov/pubme 
d/) to obtain the publication in which the sequence was described, 
from which we collected minimum inhibitory concentration (MIC) 
values of the respective β‐lactamase enzymes and β‐lactam antibiot‐
ics, whenever this information was available. Two types of MIC value 
were retrieved, with and without β‐lactamases, and we then calcu‐
lated the fold change (MIC value of with β‐lactamase was divided by 
without β‐lactamase MIC) between them. A total of 218 sequences 
were selected with these MICs against different β‐lactam antibiot‐
ics. These MICs and fold change values are also available in the β‐lac‐
tamase database (Keshri et al., 2019). Further, the fold change MIC 
values were normalized on a log scale followed by convergent evolu‐
tion study. The remaining sequences were excluded from the study 
because the sequences were published on the basis of homologous 
sequences.	Some	sequences	were	characterized	on	the	basis	of	ki‐
netic parameters, while others did not report MIC. Further informa‐
tion such as original published article, collected MIC values (with and 
without β‐lactamase), and other related information can be accessed 
in a β‐lactamase database (Keshri et al., 2019).
The MICs of the same species–strain, same experiment tech‐
nique/conditions, and specific sufficient data are not available in 
the scientific community for a particular species–strain and exper‐
iment convergent evolution study. Therefore, it is not possible to 
analyze data in species and/or strain and expression system specific. 
Generally, for comparison of MICs between different experiments, it 
is also necessary to perform experiment in the same laboratory with 
similar experimental protocols for removing the technical variability. 
Unfortunately, this kind of specific datasets is not available. Because 
of these difficulties, we initiated to analyze all MIC data (regardless 
of specific species, strain, techniques, etc) of a particular class of β‐
lactamase enzymes and correlate with their phylogenetic trees (each 
molecular class separately).
2.2 | Multiple sequence alignment and 
phylogenetic inference
The multiple sequence alignment and phylogenetic tree reconstruc‐
tions	 were	 conducted	 in	 MEGA6	 version	 6.05	 (Tamura,	 Stecher,	
Peterson,	Filipski,	&	Kumar,	2013).	Sequences	were	aligned	using	the	
MUSCLE	algorithm	 (Edgar,	2004)	with	default	settings.	The	phyloge‐
netic trees were constructed with the maximum‐likelihood method 
under	a	WAG	+	G+I	amino	acid	 substitution	model	 (estimated	 to	be	
the best substitution model by maximum‐likelihood‐based model com‐
parison, also in MEGA6). Node support was estimated using 1,000 
bootstrap replicates. The phylogenetic trees were midpoint‐rooted, 
and branch lengths of the phylogenetic trees were converted to rela‐
tive time (“dated” with the total length of the tree equal to 1) using 
maximum penalized likelihood as implemented in the chronos function 
in	the	ape	package	of	R	3.3.0	(Paradis,	Claude,	&	Strimmer,	2004).	In	
this article, we use the term “dated” for convenience (recognizing that 
no absolute date has been estimated). The chronos function allows dif‐
ferent types of clock models including strict, correlated, relaxed clocks 
and	discrete	rate	models.	We	fit	each	of	these	models,	 including	dis‐
crete rate models with the number of rates ranging from a single rate 
for the tree (equivalent to a strict clock model) to a separate rate for 
each branch in the tree. In all cases, the relaxed clock model provided 
the best fit, as indicated by having the highest probability of penalized 
log‐likelihood, which was therefore used for the dating of all trees here.
2.3 | Identifying convergent evolution
We	 estimated	 the	 ancestral	 functional	 activity	 over	 the	 tree	 using	
maximum‐likelihood (ML) estimation via the contMap function in the 
phytools package (Revell, 2012). Before conducting the analysis, we 
first logged the values of functional activity (MIC fold change), since 
the raw values varied exponentially, which can cause the estima‐
tion of ancestral states to perform poorly. Our results as presented 
are therefore based on estimated ancestral values of log (MIC fold 
change) rather than the raw activity values. A Python script (provided 
in	Appendix	S1)	was	used	for	the	identification	of	amino	acid	residues	
that are potentially responsible for functional convergence. This script 




Based on our ML estimation of ancestral enzyme activity, we ob‐
served convergent evolution of antibiotic resistance in each molecu‐
lar class A‐D, which we discuss in details for each class below.
3.1.1 | Class A
The phylogenetic tree of class A β‐lactamases shows evidence for 
a convergent evolution of function with respect to the cefepime 
(Figure 1) and cephalothin antibiotics (Figure 2). The ancestral activ‐
ity was estimated as moderately resistant (green color) to cefepime 
and cephalothin antibiotics. However, this may be partly due to 
F I G U R E  2   Class A (Cephalothin): The midpoint‐rooted phylogenetic tree was constructed by maximum‐likelihood method based on the 
multiple sequence alignment. Bootstrap values are shown on each node. The phylogenetic tree contains class A β‐lactamases. The color 
of the branch (also in scale bar) indicates functional activity of enzymes against cephalothin β‐lactam antibiotic. The color scheme and 
annotations are identical to those in Figure 1
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the trend in the methods used to estimate ancestral states from 
continuous data to estimate near‐average values at the root, un‐
less there is strong evidence to support otherwise. As they evolve, 
the	function	of	certain	enzymes	(VEB‐1,	GES‐2,	GES‐18,	TEM‐134,	
TEM‐30,	TEM‐141,	SHV‐72,	SHV‐48,	SHV‐49,	AST‐1,	KPC‐4,	SME‐1,	
BIC‐1, and RAHN‐2 for cefepime, and TEM‐125, TEM‐187, TEM‐30, 
TEM‐59,	 and	 SHV‐72	 for	 cephalothin)	 becomes	 susceptible	 to	 the	
antibiotic. On the other hand, the activity of enzymes CTX‐M‐19, 
CTX‐M‐8, CTX‐M‐40, CTX‐M‐72, TEM‐149, TEM‐131, TEM‐87, 
TEM‐71‐72, and CRAB‐10 for cefepime antibiotics remains un‐
changed and exhibits a similar functional affinity (moderately resist‐
ant	to	cefepime)	when	compared	to	their	ancestors.	Similarly,	in	the	
case	of	cephalothin,	the	CTX‐M,	GES,	PER	group	of	enzymes	has	a	
similar scale of activity compared to that of their ancestor. Most of 
the modern enzymes reveal moderate resistance (green color) with 
respect to cephalothin (Figure 2). The CTX‐M‐32, CTX‐M‐33, and 
SFO‐1	indicate	a	strong	resistance	to	cefepime	antimicrobial	agents,	
and this resistance appears to have evolved independently in each 
of	those	three	enzymes	(Figure	1).	SED‐1	also	has	high	resistance	to	
cephalothin, and lower increases in resistance have evolved inde‐
pendently in additional lines.
3.1.2 | Class B
Metallo‐β‐lactamase enzymes show evidence of a convergent 
evolution of both high levels of susceptibility and resistance to the 
antibiotic	 piperacillin	 (Figure	 3).	 For	 instance,	 the	GOB,	 B,	 TUS,	
MUS,	 and	 IMP	groups	 (except	 IMP‐44),	VIM‐7,	VIM‐13,	VIM‐34,	
VIM‐31, VIM‐15, VIM‐18, VIM‐24, and VIM‐16 show an increased 
susceptibility to piperacillin (decreasing functional affinity), while 
the NDM‐4, VIM‐38, VIM‐26, and IMP‐44 enzymes have inde‐
pendently evolved to be moderately resistant (green) to pipera‐
cillin. The IMIH enzyme appears to be highly resistant (red) to 
piperacillin.
The ancestral state shows susceptibility to imipenem antimicro‐
bial	agents	 (Figure	S1),	and	this	activity	retained	 in	some	enzymes	
such as IMP‐10, IND‐3, VIM‐19, VIM‐38, and VIM‐26. Exceptionally, 
the functional affinities of group B (B‐1, B‐3, B‐9‐13) are entirely dif‐
ferent from those of their last ancestors, and the enzyme reveals a 
further decrease in their functional (sensitive) affinity to imipenem. 
The IMIH β‐lactamase exhibits a strong resistance (strong functional 
affinity) to imipenem compared to ancestral. Meropenem also shows 
evidence of functional convergent evolution in β‐lactamase enzymes 
(Figure	S2).	The	ancestral	activity	seems	fairly	susceptible	to	mero‐
penem, while modern enzymes, such as GOB, B, VIM‐16, VIM‐24, 
VIM‐18, VIM‐15, VIM‐31, VIM‐13, and VIM‐7, are highly susceptible 
(blue color indicates lower MIC fold). However, it is more strongly 
supported by the fact that IMIH enzymes have a high resistance 
to meropenem, while VIM‐26, VIM‐38, IMP‐44, and NDM‐4 have 
a moderate resistance compared to IMIH. The above enzymes are 
distributed in different clades of the tree and display the indepen‐
dent evolution of the functions. The functional evolution of subclass 
B1 and B3 was estimated separately, and we observed that subclass 
B3	 (Figures	 S7‐S9)	 does	 not	 exhibit	 any	 functional	 convergence,	
only a single origin of strong resistance in IMIH to imipenem and 
meropenem and in AIM‐1 to piperacillin. The subclass B1 exhibits a 
functional convergence in imipenem, meropenem, and piperacillin 
antibiotics	(Figure	S4‐S6).	The	evolution	of	the	functional	activity	of	
resistance was estimated in the NDM and IMP enzymes compared 
to the antibiotics imipenem and meropenem. For piperacillin, the 
BlaB,	MUS,	 and	 IMP	enzymes	 showed	 a	 reduced	 activity	 as	 com‐
pared to the ancestral moderate resistance, while DIM, NDM‐4, and 




ancestral function was estimated as moderate resistance (green 
color) to cefoxitin, but the distantly related enzymes, such as FOX‐2, 
CMY‐37, and CMY‐15, show evidence of convergent evolved resist‐
ance. Additionally, we found evidence that the enzymes ACC‐1, 
ACC‐2, ACC‐4, MOR, and DHA‐2 independently evolved increased 
sensitivity to cefoxitin (decreasing resistance).
Piperacillin‐TZB is a combination of piperacillin antibiotics and 
tazobactam inhibitors. The evolutionary connection among the new 
enzymes	and	their	functional	growth	can	be	observed	in	Figure	S3.	
This analysis has been conducted on 16 β‐lactamase enzymes that 
contained ancient resistant functional characteristics of piperacil‐
lin‐TZB. The modern enzymatic function of CMY‐9, DHA‐2, ACT‐1, 
and CMY‐32 has susceptible characteristics, and our analysis sug‐
gests that these enzymes have independently developed this sus‐
ceptibility. As compared to ancestral function, the modern enzymes 
FOX‐5, CMY‐19, ACC‐4, ACC‐1, and CMY‐36 are strongly resistant 
to piperacillin‐TZB, and this again has evolved through a convergent 
evolution.
3.1.4 | Class D
The antibiotic‐resistant function of the oxacillin molecular class D, 
with respect to imipenem, has evolved convergently in at least two 
lineages (Figure 5). The inferred ancestral state is that the functional 
activity of ancestral enzymes was highly susceptible to carbap‐
enem (Imipenem) which remains an attribute of the vast majority of 
forms of the enzyme. However, some enzymes (OXA‐24, OXA‐160, 
OXA‐133, OXA‐58, OXA‐60, OXA‐20, OXA‐48, OXA‐163, OXA‐54, 
F I G U R E  3   Class B (Piperacillin): The midpoint‐rooted phylogenetic tree was constructed by maximum‐likelihood method based on the 
alignment. Bootstrap values are shown on each node. The phylogenetic tree contains class B β‐lactamases. The color of the branch (also in 
scale bar) indicates functional activity of enzymes against piperacillin β‐lactam antibiotic. The color scheme and annotations are identical to 
those in Figure 1
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and OXA‐55) have lost their ancestral functional characteristics and 
evolved resistant to imipenem antibiotics. In particular, the enzyme 
OXA‐133 is highly resistant (red color) to imipenem, and since this 
enzyme is deeply nested in a clade which shows slightly increased 
levels of resistance over the ancestral state, this may suggest that 
antibiotic resistance in OXA‐133 has evolved in a “rachet‐like” man‐
ner as moderate resistance sets the stage for high levels of resistance 
in	later	descendants.	Such	a	“stepped”	evolution	of	toxin	resistance	
(of which antibiotic resistance is type) has previously been demon‐
strated in the evolution of resistance to tetrodotoxin in salamanders 
(Hanifin & Gilly, 2015), and the generality of such a mechanism is 
worth further investigation. The imipenem‐resistant class D en‐
zymes appear to have evolved on three separate occasions, and in 
combination with the other results discussed above, this highlights 
the remarkable frequency of convergent evolution in β‐lactamase‐
mediated antibiotic resistance.
3.2 | Convergent amino acid residue identification
We	investigated	whether	the	convergent	functional	evolution	we	
observed at the intraclass level of β‐lactamase superfamilies was 
mediated by underlying convergence at the molecular sequence 
F I G U R E  4   Class C (Cefoxitin): The 
midpoint‐rooted phylogenetic tree was 
constructed by maximum‐likelihood 
method based on the alignment. 
Bootstrap values are shown on each node. 
The phylogenetic tree contains class 
C β‐lactamases. The color of the branch 
(also in scale bar) indicates functional 
activity of enzymes against cefoxitin 
β‐lactam antibiotic. Blue through red 
color indicated susceptible to resistance 
functional activity
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level	(i.e.,	whether	the	same	mutations	conferred	resistance).	We	
attempted to identify amino acid residues that may be respon‐
sible for functional changes using a python script (provided in 
Appendix	S1)	which	looks	for	convergent	mutations	that	co‐occur	
on the phylogeny with each similar change in the functional activ‐
ity. However, we did not identify any strong candidate amino acid 
residue. This may be due to resistance being conferred by changes 
in (a) the 3D structure of the enzymes (Molina‐Mora & Morgan, 
2016), (b) combinatorial effects of multiple amino acid changes, but 
a different combination in each case, (c) properties that are shared 
among multiple different amino acids, for instance, if changes in 
charge were important regardless of the specific amino acid that 
caused the change, or (d) homologous sequence identity/similarity 
threshold criteria. Therefore, future work to identify the molecular 
changes responsible for modifying the functional activity of these 
enzymes will require a more targeted approach that takes full ac‐
count of the range of molecular mechanisms of protein evolution. 
We	are	therefore	not	able	to	report	the	underlying	molecular	basis	
of the functional convergence we document, but we can affirm 
that neither the change of a single amino acid nor a fixed combi‐
nation of changes is responsible for all the functional changes we 
document here. This has crucial implications for the identification 
of resistant phenotypes, as it suggests that it may not be possible 
to develop sequence‐based bioinformatic approaches to identify‐
ing resistance, which will therefore require more resource‐inten‐
sive (but accurate) methods such as functional assays.
4  | CONCLUSION
In this study, we present evidence of frequent convergent func‐
tional evolution of β‐lactamase function conferring resistance to 
a broad range of commonly used antibiotics. Functional variation 
and convergent similarities occur in distant related enzymes, indi‐
cating that resistance to antibiotics mediated by β‐lactamase can‐
not necessarily be inferred by sequence similarity alone or by the 
F I G U R E  5   Class D (Imipenem): The 
midpoint‐rooted phylogenetic tree was 
constructed by maximum‐likelihood 
method based on the alignment. 
Bootstrap values are shown on each node. 
The phylogenetic tree contains class 
D β‐lactamases. The color of the branch 
(also in scale bar) indicates functional 
activity of enzymes against imipenem 
β‐lactam antibiotic. Blue through red 
color indicated susceptible to resistance 
functional activity. Blue indicates 
susceptible, Green moderately resistant, 
and red highly resistant
10  |     KESHRI Et al.
phylogenetic	 relationship.	 We	 therefore	 suggest	 that,	 although	
bioinformatic tools to extract antibiotic resistance information 
from amino acid sequences are in principle more efficient than lab‐
oratory functional tests, they are ineffective and functional assays 
are essential to assess antibiotic resistance. Functional convergent 
evolution appears to be a common pattern of antibiotic resistance 
(at least for β‐lactamase) and may therefore provide a useful com‐
parative system for studies of convergence across different levels 
of life. In addition, testing three‐dimensional molecular structures 
for structural similarity and analyzing biological pathways that 
reflect the functional relationship could open the way to other 
possibilities for predicting antibiotic resistance. Nonetheless, β‐
lactamase evolution demonstrates that the dynamics of conver‐
gent evolution can differ across different levels of life (e.g., from 
primary sequence structure to function) in a medically important 
system, providing opportunities to apply our evolutionary under‐
standing to the management of infections.
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